doi: 10.1038/nm.3394
A recent analysis utilizing five US national healthcare claims cohorts from 2018 to 2024 simulated the STEP-HFpEF DM (semaglutide) and SUMMIT (tirzepatide) trials to benchmark outcomes and expanded the eligibility criteria to reflect real-world clinical practice
She got to know me and my medical background and really connects with her patients
Some patients tolerate Mounjaro more easily than Wegovy
We currently serve Greenville SC, Asheville NC, Charlotte NC, Raleigh NC, Knoxville TN, Nashville TN, Atlanta GA, and Houston TX
How Our Clinic Eases Drug Testing Concerns At TrimBody M.D., we answer questions about work-related tests, health exams, and sharing medication details